Skip to main content

Artificial pancreas systems

Artificial pancreas systems

08-10-2021 | Artificial pancreas systems | News

Fully closed-loop insulin delivery not yet a match for precise carb counting

A dual-hormone fully closed-loop system did not demonstrate non-inferiority to a hybrid system in a randomized trial, despite producing a high time in range, report the researchers.

01-10-2021 | EASD 2021 | Conference coverage | News

Cambridge closed-loop system benefits very young children over 4 months of use

Closed-loop control with the Cambridge hybrid system improves time in range in very young children with type 1 diabetes relative to sensor-augmented pump delivery over 16 weeks of use, researchers report.

10-08-2021 | Artificial pancreas systems | News

Closed-loop system improves glycemic control in people with type 2 diabetes on dialysis

Findings from an exploratory randomized crossover trial suggest that closed-loop insulin delivery leads to better glycemic control than standard insulin treatment in people with type 2 diabetes and end-stage renal disease requiring maintenance dialysis in the outpatient setting.

28-06-2021 | ADA 2021 | Conference coverage | News

Cambridge closed-loop system benefits children, adolescents over 6 months of use

The Cambridge closed-loop insulin delivery system significantly improves glycemic control during 6 months of use by children and adolescents compared with standard insulin pump therapy, report the DAN05 investigators.

27-06-2021 | ADA 2021 | Conference coverage | News

Omnipod 5 system use reduces diabetes distress

Use of the Omnipod 5 closed-loop insulin delivery system reduces diabetes distress and improves quality of life, particularly for the carers of children with type 1 diabetes, research shows.

27-06-2021 | ADA 2021 | Conference coverage | News

Omnipod 5 closed-loop system success in preschoolers

The Omnipod 5 tubeless automated insulin delivery system improves glycemic outcomes of very young children with type 1 diabetes and the sleep of their caregivers, report researchers.

05-06-2021 | ATTD 2021 | Conference coverage | News

AI may facilitate fully closed-loop insulin delivery

A closed-loop system with an artificial intelligence component that rapidly detects when the user is eating a meal may offer a route towards fully closed-loop insulin delivery, shows a small crossover trial in adolescents and young adults.

05-06-2021 | ATTD 2021 | Conference coverage | News

Forthcoming consensus statement offers guidance on DIY closed-looping

A consensus statement covering the practical, ethical, and legal aspects of the use of open-source closed-loop insulin delivery algorithms is soon to be published, the authors reported at the virtual ATTD 2021 conference.

16-04-2021 | Artificial pancreas systems | News

Large study illustrates efficacy of Loop DIY automated insulin delivery

A large real-world study shows improved glycemic outcomes for adults and children who initiate use of the Loop DIY automated insulin delivery system using community resources.

10-02-2021 | Empagliflozin | News

Adding empagliflozin to closed-loop insulin may reduce need for carbohydrate counting

Among people with type 1 diabetes, adding the SGLT2 inhibitor empagliflozin to an automated insulin delivery system may allow replacement of carbohydrate counting with a simple meal announcement, suggest findings from a pilot randomized trial.

Artificial pancreas concept

06-11-2020 | Artificial pancreas systems | News

Closed-loop system shows promise for people with unstable type 1 diabetes

A closed-loop insulin delivery system may offer significantly better glycemic control than an open-loop system with predictive low glucose suspend in islet transplant candidates with highly unstable type 1 diabetes, research shows.

25-09-2020 | EASD 2020 | Conference coverage | News

Fully closed-loop insulin delivery edges closer with pramlintide–faster aspart system

A fully automated dual-hormone delivery system with pramlintide and faster-acting insulin aspart delivers overall glycemic control that is nearly as good as that achieved with a hybrid closed-loop system with the insulin only, report researchers at the virtual 56th EASD Annual Meeting.

04-09-2020 | Children | News

FDA okays MiniMed 770G for young children

Click through to read more on this announcement

26-08-2020 | Artificial pancreas systems | News

​​​​​​​Closed-loop system improves glycemic control in children with type 1 diabetes

Children with type 1 diabetes who use the Tandem Control-IQ hybrid closed-loop insulin delivery system spend more time with their blood glucose levels in the target range than those using a sensor-augmented insulin pump, show findings from the iDCL trial.

Rayhan Lal

23-06-2020 | ADA 2020 | Podcast | Article

Expert commentary: Closed-loop insulin delivery research update

Engineer turned endocrinologist Rayhan Lal reflects on the shape of artificial pancreas research and what changes are needed to best benefit people with diabetes (18:54).

13-06-2020 | ADA 2020 | Conference coverage | News

​​​​​​​Omnipod Horizon system effective and well liked in outpatient trial

The Omnipod Horizon closed-loop system has delivered good glucose control in its first outpatient study, the investigators report.

Medtronic MiniMed™ 670G

13-06-2020 | ADA 2020 | Conference coverage | News

FLAIR: Upgraded MiniMed closed-loop system outperforms predecessor

The Medtronic MiniMed Advanced Hybrid Closed-Loop system delivers better glycemic control than the currently approved 670G system, shows the international FLAIR trial.

10-02-2020 | Artificial pancreas systems | News

Greatest beneficiaries of closed-loop systems not always as HCPs assume

Healthcare professionals can make false assumptions about which children with type 1 diabetes will gain most from closed-loop insulin delivery, risking children who could potentially benefit missing out, research suggests.

29-01-2020 | Artificial pancreas systems | News

Rapid insulin–pramlintide artificial pancreas improves glycemic control in type 1 diabetes

A novel artificial pancreas that delivers both rapid insulin and pramlintide improves glycemic control compared with one that delivers rapid insulin alone, without increasing hypoglycemia rates, in people with type 1 diabetes, Canadian research shows.

21-01-2020 | Artificial pancreas systems | News

Phone-controlled closed-loop insulin delivery an ‘appealing alternative’

A randomized trial shows the feasibility of closed-loop insulin delivery controlled by an algorithm on a user’s phone rather than in their pump, but also highlights issues with connectivity.